MedTrace Logo

Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty

NCT02299271 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2017-02-09

No results posted yet for this study

Summary

This study evaluates post-operative pain management and narcotic consumption in patients receiving a fascia iliaca block with local anesthetic versus patients receiving fascia iliaca block with saline for total hip arthroplasty.

Conditions

  • Osteoarthritis of the Hip

Interventions

DRUG

Ropivacaine

0.375% ropivacaine as a one-time, 60 milliliter injection

DRUG

Saline

Saline as a one-time, 60 milliliter injection.

Sponsors & Collaborators

  • The Christ Hospital

    lead OTHER

Principal Investigators

  • Brian Vaughan, MD · The Christ Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02299271 on ClinicalTrials.gov